CYTOGENETIC CONVERSION IN A CASE OF POLYCYTHEMIA-VERA TREATED WITH INTERFERON-ALPHA

被引：51

作者：

MESSORA, C ^{[1
]}

BENSI, L ^{[1
]}

VECCHI, A ^{[1
]}

LONGO, R ^{[1
]}

GIACOBBI, F ^{[1
]}

TEMPERANI, P ^{[1
]}

BEVINI, M ^{[1
]}

EMILIA, G ^{[1
]}

SACCHI, S ^{[1
]}

机构：

[1] UNIV MODENA,POLICLIN,IST CLIN MED 2,I-41100 MODENA,ITALY

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1994年 / 86卷 / 02期

关键词：

POLYCYTHEMIA VERA; IFN; CHROMOSOME CONVERSION;

D O I：

10.1111/j.1365-2141.1994.tb04752.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Polycythaemia vera is a clonal disorder of the haemopoietic stem cell causing a pathologic expansion of the erythroid and sometimes the megakaryocytic and myeloid elements. In order to avoid the possible mutagenic effects of radioactive phosphorus, alkylating agents and hydroxyurea, since 1988 cr-IFN has been used for the treatment of PV and has been shown to induce and maintain haematological remission. We describe a 24-year-old PV patient with chromosomal abnormalities who achieved not only a reduction of the proliferation of erythroid elements and reticulin content in the bone marrow, but also a complete cytogenetic remission after IFN treatment.

引用

页码：402 / 404

页数：3

共 50 条

[41] Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hasselbalch, Hans Carl
Holmstroem, Morten Orebo
SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) : 5 - 19
[42] HEMORHEOLOGY IN TREATED POLYCYTHEMIA-VERA - THE ROLE OF HYPOCHROMIC MYCROCYTOSIS AND OF PLASMA VISCOSITY
PALARETI, G
FINELLI, C
POGGI, M
TRICARICO, MG
FIACCHINI, M
RICCI, P
TURA, S
COCCHERI, S
CLINICAL HEMORHEOLOGY, 1986, 6 (01): : 99 - 108
[43] INFLUENCE OF CELL-SIZE ON ERYTHROCYTE DEFORMABILITY IN TREATED POLYCYTHEMIA-VERA
KENNY, MW
GYDE, OHB
STUART, J
CLINICAL HEMORHEOLOGY, 1984, 4 (04): : 381 - 386
[44] ACUTE MYELOBLASTIC-LEUKEMIA WITH POLYCYTHEMIA-VERA - TREATED WITH BUSULFAN AND PHLEBOTOMY
DITTMAR, K
NEW YORK STATE JOURNAL OF MEDICINE, 1979, 79 (05) : 758 - 761
[45] POLYCYTHEMIA-VERA IN CHILDHOOD - CASE-REPORT AND REVIEW OF THE LITERATURE
DANISH, EH
RASCH, CA
HARRIS, JW
AMERICAN JOURNAL OF HEMATOLOGY, 1980, 9 (04) : 421 - 428
[46] Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in Polycythemia Vera
Foa, P
Massaro, P
Caldiera, S
LaTargia, M
Iurlo, A
Fornier, M
Bertoni, F
Maiolo, AT
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 381 - 381
[47] POLYCYTHEMIA-VERA IN AN ORAL SURGICAL PATIENT - A CASE-REPORT
CARLSON, ER
CHEWNING, LC
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1989, 67 (06): : 673 - 675
[48] Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hans Carl Hasselbalch
Morten Orebo Holmström
Seminars in Immunopathology, 2019, 41 : 5 - 19
[49] SYSTEMIC MASTOCYTOSIS - A CASE TREATED WITH INTERFERON-ALPHA AND RADIOTHERAPY
HARRISON, BD
ASHFORD, RA
HATTON, CSR
CLINICAL AND LABORATORY HAEMATOLOGY, 1994, 16 (03): : 291 - 294
[50] POLYCYTHEMIA-VERA TERMINATING IN CHRONIC NEUTROPHILIC LEUKEMIA - REPORT OF A CASE
IURLO, A
FOA, P
MAIOLO, AT
LUKSCH, R
CAPSONI, F
POLLI, EE
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (02) : 139 - 139

← 1 2 3 4 5 →